Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Tool, Dx Stocks Outperformed Pharma, Biotech in December, Report Shows

NEW YORK, Dec. 7 (GenomeWeb News) - Shares in genomic-based diagnostics and tools companies outperformed big drug makers and firms in other healthcare industry segments, according to a Pacific Growth Equities report analyzing stocks in the healthcare industry.

 

The weighted average total return of 109 diagnostic- and tool-company stocks analyzed by the investment bank increased 9.44 percent in December, compared with 7.66 percent for 151 medical technology stocks; 7.54 percent for 303 drugs stocks; 6.37 percent for nine "ancillary" stocks; and 5.65 percent for 71 services stocks.

 

Diagnostics and tools stocks included companies such as Applied Biosystems, whose shares increased 2 percent during the month; Cepheid, whose shares increased 7.93 percent; Charles River Labs, whose shares increased 1.58 percent; Ciphergen, whose shares increased 33.54 percent; Harvard Biosciences, whose shares increased 16.92 percent; Illumina, whose shares increased 24.74 percent; Invitrogen, whose shares increased 10.96 percent; Strategene, whose shares increased 5.56 percent; and Third Wave Tech, whose shares increased 6.7 percent.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.